[Ertapenem].
Gobernado
M
M
Servicio de Microbiologia, Hospital Universitario La Fe, Valencia, Spain.
Acuña
C
C
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002473:Cell Wall / Q000187:drug effects; D002648:Child; D048909:Diabetes Complications / Q000188:drug therapy; D004311:Double-Blind Method; D016527:Drug Costs; D004357:Drug Synergism; D000077727:Ertapenem; D005260:Female; D006801:Humans; D008297:Male; D009765:Obesity / Q000378:metabolism; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D014018:Tissue Distribution; D018440:beta-Lactam Resistance; D047090:beta-Lactams / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D000077727:Ertapenem